| | july 20146CIOReviewCopyright © 2014 CIOReview, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.CIOReviewJULY - 2014CIOReview's circulation is audited and certified by BPA International (Audit Pending). Mailing AddressCIOReview44790 S. Grimmer Blvd Suite 202, Fremont, CA 94538T:510.402.1463, F:510-894-8405 July 2014, volume SE 12 Published by CIOReview To subscribe to CIOReviewVisit www.cioreview.com Editor-in-Chief Pradeep ShankarManaging Editor Christo JacobEditorial StaffSalesAlex DHarvi SacharRuby JonasEmma WilkinsNeha KuduvalliRyan MaxT:510.565.7559 VisualizersStephen ThomasMohammed HaneefPharma and Life Sciences Technology SpecialCIOReviewAnnieMetildaannie@cioreview.com Benny Thomasbenny@cioreview.com Stephen Thomasstephen.thomas@cioreview.com John Varghesejohn.varghese@cioreview.com Sarah FernandesThe pharmaceutical and life sciences market is competitive and rapidly changing. Whether it's driving process improvements to clinical operations, increasing sales effectiveness, or enhancing drug safety, life sciences companies are redefining the way they leverage technology.For life sciences organizations, clinical trials are often the largest source of any R&D budget. However, as regulatory requirements continue to tighten and research and development costs continue to rise, there is an ever-growing need to improve productivity. Historically, this has meant large trials and a focus on data gathering, collection and analysis. This approach increases cost but does not consistently improve outcomes. Such an environment offers an abundance of new opportunities for improvement using big data and analytics--from cloud computing to executing radically smaller, faster and cheaper clinical trials by combining genomic markers and real-world big data analytics.As life sciences organizations face newer challenges, being effective with data becomes essential for sustained success. Leveraging data management and analytics technologies, life sciences organizations can turn data into innovative insights. Those who understand how to manage data relevant to their products, markets and customers will create the opportunity for competitive advantage based on improved insight.On a different front, customers' needs have become more and more sophisticated, but weaknesses in the supply chain can make it impossible to meet those needs. Now, more than ever, pharmaceutical and life sciences companies must make investments in analyzing and monitoring every link in their supply chains.In this special edition of CIO Review, CIOs from leading pharmaceutical and life sciences companies share their experiences of leveraging technology in their business environment.We also present to you most promising pharma and life sciences solution providers and consulting companies and highlight what these selected vendors are doing for their clients. We hope the information presented will give you a comprehensive understanding of what technologies are available, which is right for you, and how these solutions will impact your business.We would love to hear your experiences of how technology is playing a critical role in driving your business.Let us know what you think, Pradeep ShankarEditor-in-Chiefeditor@cioreview.comEditorialDriving a Changing Data Landscape
< Page 5 | Page 7 >